Docstoc

Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017

Document Sample
Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017 Powered By Docstoc
					Brochure
More information from http://www.researchandmarkets.com/reports/1397943/




Stomach Cancer - Pipeline Assessment and Market Forecasts to
2017

Description:    Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017

                Summary

                Our report, “Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017”, is an essential
                source of information and analysis on the global stomach cancer market. The report identifies the
                key trends shaping and driving the global stomach cancer market. The report also provides insights
                into the prevalent competitive landscape and the emerging players expected to alter the market
                position of the current market leaders. Most importantly, the report provides valuable insights into
                the pipeline products in the global stomach cancer segment.
                This report is built using data and information sourced from proprietary databases, primary and
                secondary research and in-house analysis by Our team of industry experts.

                Our analysis suggests that the global gastric cancer market was worth $750m in 2009. It is
                forecast to grow at a Compound Annual Growth Rate (CAGR) of 8.3% to $1,422m in 2017. Most of
                the chemotherapies are already off-patent while Taxotere and Xeloda are expected to lose their
                patents during 2010 to 2011. Taxotere’s generic version, produced by Hospira, has already been
                approved in Europe through the decentralized procedure. The market is expected to be driven by
                the increase in demand due to the launch of promising targeted therapies currently in the late
                stage of development. The pending approval of Herceptin in the US and Japan will also boost the
                revenues generated in the stomach cancer market. However, the new therapies are not expected
                go off-patent before 2017. Therefore, the market is expected to witness strong growth in market
                revenues in the forecast period.

                Scope

                The scope of the report includes:
                - Annualized global stomach cancer market revenues data from 2001 to 2009, forecast for eight
                years to 2017.
                - Geographies covered in this report include the United States (US), the United Kingdom (UK),
                Italy, Spain, Germany, France and Japan.
                - Pipeline analysis data split across different phases by mechanism of action and emerging trends.
                The key classes of mechanism of action are mTOR inhibitors, PARP inhibitors, microtubule
                inhibitors, VEGFR inhibitors, multiple tyrosine kinase inhibitors, Heat Shock Protein 90 inhibitors,
                Eg5 inhibitors, Farnesyl-OH-transferase inhibitors, angiogenesis inhibitors and combinations of
                several existing chemotherapies.
                - Analysis of the current and future competition in the global stomach cancer market. The key
                market players covered include GlaxoSmithKline, Novartis Pharmaceuticals, Merck & Co, Eli Lilly
                and Company, Amgen, Hoffmann-La Roche and Pfizer Inc.
                - Insightful review of the key industry drivers, restraints and challenges. Each trend is
                independently researched to provide a qualitative analysis of its implications.
                - Key topics covered include a strategic competitor assessment, market characterization, unmet
                needs and the implications for the future stomach cancer market

                Reasons to buy

                The report will enhance your decision making capability. It will allow you to:
                - Develop and design your in-licensing and out-licensing strategies through a review of the pipeline
                products and technologies and by identifying the companies with the most promising product
                candidates in the pipeline.
                - Develop business strategies by understanding the trends shaping and driving the global stomach
                cancer market.
                - Drive revenues by understanding the key trends, innovative products and technologies, market
                segments and companies likely to impact the global stomach cancer market in future.
            - Formulate effective sales and marketing strategies by understanding the competitive landscape
            and by analyzing the performance of various competitors.
            - Identify emerging players with potentially strong product portfolio and create effective counter-
            strategies to gain a competitive advantage.
            - Organize your sales and marketing efforts by identifying the market categories and segments that
            present the maximum opportunities for consolidation, investments and strategic partnerships.
            - What’s the next big thing in the global stomach cancer market landscape? - Identify, understand
            and capitalize.



Contents:   1 Table of contents
            1.1 List of Tables
            1.2 List of Figures
            2 Stomach Cancer Introduction
            2.1 Pipeline Report Guidance
            3 Stomach Cancer: Market Characterization
            3.1 Overview
            3.2 Stomach Cancer Market Size
            3.3 Stomach Cancer Market Forecast and CAGR
            3.4 Drivers and Barriers for the Stomach Cancer Market
            3.4.1 Drivers for the Stomach Cancer Market
            3.4.2 Barriers for the Stomach Cancer Market
            3.5 Opportunity and Unmet Need
            3.6 Key Takeaway
            4 Stomach Cancer Market: Competitive Assessment
            4.1 Overview
            4.2 Strategic Competitor Assessment
            4.3 Product Profiles of Major Marketed Drugs in the Stomach Cancer Market
            4.3.1 Herceptin (trastuzumab)
            4.3.2 Taxotere (docetaxel)
            4.3.3 Xeloda
            4.3.4 Gleevec (imatinib)
            4.4 Key Takeaway
            5 Stomach Cancer Market: Pipeline Assessment
            5.1 Overview
            5.2 Strategic Pipeline Assessment
            5.2.1 Technology Trends Analytic Framework
            5.3 Stomach Cancer - Promising Drugs Under Clinical Development
            5.4 Molecule Profile for Promising Drugs Under Clinical Development
            5.4.1 Tykerb (Lapatinib)
            5.4.2 Afinitor (Everolimus)
            5.4.3 IMC-1121B (ramucirumab)
            5.4.4 Cetuximab plus capecitabine and cisplatin
            5.4.5 Apatinib (YN968DI)
            5.5 Stomach Cancer Market - Clinical Pipeline by Mechanism of Action
            5.6 Stomach Cancer Market - Pipeline by Clinical Phase of Development
            5.6.1 Stomach Cancer Market - Phase III Clinical Pipeline
            5.6.2 Stomach Cancer Market - Phase II Clinical Pipeline
            5.6.3 Stomach Cancer Market - Phase I Clinical Pipeline
            5.6.4 Stomach Cancer Market - Pre-Clinical Pipeline
            5.6.5 Stomach Cancer Market Filed Molecules Pipeline
            5.7 Key Takeaway
            6 Stomach Cancer: Implications for Future Market Competition
            7 Stomach Cancer Market: Future Players in the Stomach Cancer Market
            7.1 Introduction
            7.2 GlaxoSmithKline
            7.2.1 Company Overview
            7.2.2 Financial Performance
            7.2.3 Business Description
            7.3 Novartis AG
            7.3.1 Company Overview
            7.3.2 Financial Performance
            7.3.3 Business Description
            7.4 Eli Lilly and Company
            7.4.1 Company Overview
            7.4.2 Financial Performance
            7.4.3 Business Description
            7.5 Merck & Co
            7.5.1 Company Overview
            7.5.2 Financial Performance
            7.5.3 Business Description
            7.6 Amgen
            7.6.1 Company Overview
            7.6.2 Financial Performance
            7.6.3 Business Description
            7.7 Hoffmann-La Roche Ltd.
            7.7.1 Company Overview
            7.7.2 Financial Performance
            7.7.3 Business Description
            7.8 Pfizer
            7.8.1 Company Overview
            7.8.2 Financial Performance
            7.8.3 Business Description
            8 Stomach Cancer Market: Appendix
            8.1 Definitions
            8.2 Acronyms
            8.3 Research Methodology
            8.3.1 Coverage
            8.3.2 Secondary Research
            8.3.3 Forecasting
            8.3.4 Primary Research
            8.3.5 Expert Panels
            8.4 Contact Us
            8.5 Disclaimer
            8.6 Sources



Ordering:   Order Online - http://www.researchandmarkets.com/reports/1397943/

            Order by Fax - using the form below

            Order by Post - print the order form below and sent to

                         Research and Markets,
                         Guinness Centre,
                         Taylors Lane,
                         Dublin 8,
                         Ireland.
                                                           Page 1 of 2

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

http://www.researchandmarkets.com/contact/

Order Information
Please verify that the product information is correct and select the format(s) you require.


               Product Name:           Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017
               Web Address:            http://www.researchandmarkets.com/reports/1397943/
               Office Code:            OC8IHKSLQQNXR

Product Formats
Please select the product formats and quantity you require:


                                   Quantity
               Electronic - Site
                                         EURO €3,015.00
               License:
               Electronic -
                                         EURO €1,508.00
               Single User:
               Electronic -
                                         EURO €4,523.00
               Enterprisewide:




Contact Information
Please enter all the information below in BLOCK CAPITALS


      Title:                  Mr              Mrs           Dr           Miss                 Ms     Prof

      First Name:                                                  Last Name:

      Email Address: *

      Job Title:

      Organisation:

      Address:

      City:

      Postal / Zip Code:

      Country:

      Phone Number:

      Fax Number:

     * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
                                                              Page 2 of 2

Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.

          Pay by credit card:                     American Express

                                                  Diners Club

                                                  Master Card

                                                  Visa
                                           Cardholder's Name

                                           Cardholder's Signature

                                           Expiry Date

                                           Card Number

                                           CVV Number

                                           Issue Date
                                           (for Diners Club only)




          Pay by check:                    Please post the check, accompanied by this form, to:

                                           Research and Markets,
                                           Guinness Center,
                                           Taylors Lane,
                                           Dublin 8,
                                           Ireland.


                                           Please transfer funds to:
          Pay by wire transfer:
                                           Account number                   833 130 83
                                           Sort code                        98-53-30
                                           Swift code                       ULSBIE2D
                                           IBAN number                      IE78ULSB98533083313083
                                           Bank Address                 Ulster Bank,
                                                                        27-35 Main Street,
                                                                        Blackrock,
                                                                        Co. Dublin,
                                                                        Ireland.


     If you have a Marketing Code please enter it below:


           Marketing Code:


      Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
     http://www.researchandmarkets.com/info/terms.asp



                                              Please fax this form to:
                                  (646) 607-1907 or (646) 964-6609 - From USA
                          +353 1 481 1716 or +353 1 653 1571 - From Rest of World

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:32
posted:7/20/2012
language:English
pages:5